Amy Kim, M.D.
|
|
See our Dr. Amy Kim in a 11Alive News feature story about safe tanning!
|
|
Dr. Kim was recently quoted in the AJC. Below is a link to the article:
|
Amy Kim, M.D.
Dr. Amy E. Kim joined Metropolitan Dermatologic Surgery in September of 2005 after completing an advanced, two-year fellowship at the University of Michigan in Mohs Micrographic Surgery and cosmetic reconstruction, cutaneous oncology and melanoma, cosmetic surgery, and laser surgery. Dr. Kim earned her medical degree in 1998 from the Boston University School of Medicine and completed her internal medicine internship at Barnes Jewish Hospital of Washington University in St. Louis, Missouri in 1999. In 2003 Dr. Kim completed a research fellowship and her dermatology residency at Emory University, where she was chief resident of the program. She is board-certified by the American Academy of Dermatology and is a member of the American Society for Dermatologic Surgery and the American College of Mohs Micrographic Surgery and Cutaneous Oncology.
EDUCATION
August 1994-May 1998 Boston University School of Medicine, Boston, Massachusetts. M.D.
Alpha Omega Alpha
August 1991-May 1994 Boston University, College of Liberal Arts, Seven- Year Medical Combined Degree Program, B.A., Major: Medical Science, Minor: Psychology. Summa Cum Laude
POSTGRADUATE TRAINING
July 2003-June 2005 Mohs Surgery Fellowship. Ann Arbor, Michigan.
Timothy Johnson, M.D., Program Director
University of Michigan
2-year training program in Mohs surgery, cutaneous oncology and melanoma, cosmetic and laser procedures.
July 1999-June 2003 Emory University School of Medicine Department of Dermatology Residency Program, Atlanta, Georgia.
Chief Resident
4 year clinical and research track
June 1998-June 1999 Barnes-Jewish Hospital Internal Medicine Residency
Program: Preliminary Internship, St. Louis, Missouri.
HONORS AND AWARDS
1999 Donald C. Abele, M.D. Award: For outstanding resident presentation. Georgia Society of Dermatologists annual meeting. Sea Island, GA
Alpha Omega Alpha, Boston University School of Medicine
1998 Henry Bakst Scholarship, Boston University School of Medicine
1996 Pathology Chairs Honor Society, Boston University School of Medicine
MEMBERSHIPS AND PROFESSIONAL SOCIETIES
American Academy of Dermatology
American College of Mohs Micrographic Surgery and Cutaneous Oncology
American Society for Dermatologic Surgery
Women's Dermatologic Society
POSTERS AND PRESENTATIONS
Gira AK, Casper K,, Naik S, Caughman SW, Swerlick RA. "Inhibition of the IFN mediated Jak-STAT signaling pathway by iron chelators occurs via downregulation of the IFN receptor-1." Poster, April 2003. The Society for Investigative Dermatology Meeting.
Gira AK, Otto K, Casper K, Naik S, Koo SW, Swerlick RA. "Transcriptional and post-transcriptional regulation of interferon regulatory factor 1 expression." Poster #365. May 2002. The Society for Investigative Dermatology Meeting.
Gira AK, Robertson D, Swerlick RA. "Multiple eyelid cysts with palmoplantar hyperkeratosis." Oral Presentation. February 2002. American Academy of Dermatology meeting.
Bakotic W, Kim A, Mosunjac MB, Solomon A. "Malignant Chondroid Syringoma: Clinicopathologic correlation and review." Poster. September 2001. The American Society of Dermatopathology meeting.
Kim A, Parker SS. "Cutaneous Coccidioidomycosis: the other great imitator." Oral Presentation. June 2000. Georgia Society of Dermatology.
BIBLIOGRAPHY
Gira AK, Brown LF, Washington CV, Cohen C, Arbiser JL. "Keloids Demonstrate High Level Epidermal Expression of Vascular Endothelial Growth Factor (VEGF)." J Am Acad Dermatol. 2004 Jun;50(6):850-3.
Gira AK, Hammock L, Nolte R, Nadiminti U, Blumberg H, Caughman SW. " Mycobacterium mageritense Funrunculosis Associated with Footbaths at a Nail Salon." J Clin Microbiol. 2004 Apr;42(4):1813-7.
Gira AK, Robertson D, Swerlick RA. "Multiple eyelid cysts with palmoplantar hyperkeratosis." Arch Dermatol. 2004 Feb;140(2):231-6.
Gira AK, Casper KA, Otto KB, Nail SM, Caughman SW, Swerlick RA. "Induction of interferon regulatory factor 1 expression in human dermal endothelial cells by interferon-gamma and tumor necrosis factor-alpha is transcriptionally regulated and requires iron." J Invest Dermatol. 2003 Nov;121(5):1191-6.
Koo SW, Casper KA, Otto KB, Gira AK, Swerlick RA. "Iron chelators inhibit VCAM-1 expression in human dermal microvascular endothelial cells." J Invest Dermatol. 2003 May;120(5):871-9.
Kim A, Parker SS. "Coccidioidomycosis: Case report and update on diagnosis and management." J Am Acad Dermatol 2002;46:743-747.
Kim A, DiCarlo J, Cohen C, McCall C, Johnson D, McAlpine B, Quinn A, Mclaughlin E, Arbiser J. "Are keloids really "gli-loids"?: High level expression of gli-1 oncogene in keloids." J Am Acad Dermatol 2001;45:707-711.
Burbach G, Kim KH, Zivony AS, Kim A, Aranda J, Wright S, Naik SM, Caughman SW, Ansel JC, Armstrong CA. "The Neurosensory tachykinins substance P and neurokinin A directly induce keratinocyte nerve growth factor." J Invest Dermatol 2001;117:1075-82.
CHAPTER IN BOOKS
Chang AE, Johnson TM, Gira A. Skin and Soft Tissue: Cutaneous Neoplasms: Greenfield L, Mulholland M, Oldham K, Zelenock G, Lillemoe KD (Eds): Essentials of Surgery: Scientific Principles and Practice, 3rd Edition. Lippincott-Raven Publishers, Accepted 2005
